IMR
IMRICOR CDI FORUS [IMR]
Healthcare · ASX Small Cap
$2.1500 +0.0%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +7First seen: 2026-02-25
Score Breakdown
Technical76
Catalyst51
Sentiment50
Fundamental56
Momentum49
Risk Gate50
Active Signals
Bullish Signals
- Price above MAs (uptrend)
- Above-average volume (1.5x) on up day
- Testing resistance level
- Above 200-day MA (long-term uptrend)
- Strong cash runway (9 quarters)
- Very high P/S ratio (2360.6x)
- Revenue in sharp decline (-83%)
- Near 52-week high (91% of range)
- CANSLIM N: Near 52-week high (breakout territory)
- CANSLIM I: Institutional ownership (18%)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- Piotroski F-Score weak (3/9)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
- Revenue momentum declining (-83%)
Recent Catalysts
LOW FY25 Results Investor Presentation
NONE Imricor Releases FY25 Results
NONE Appendix 4E and FY25 Financial Accounts
NONE Na Homolce to Become 3rd Site for VISABL-VT
Recent ASX Announcements
| 2026-02-24 | FY25 Results Investor Presentation PRICE SENSITIVE |
| 2026-02-24 | Imricor Releases FY25 Results PRICE SENSITIVE |
| 2026-02-24 | Appendix 4E and FY25 Financial Accounts PRICE SENSITIVE |
| 2026-02-17 | Na Homolce to Become 3rd Site for VISABL-VT PRICE SENSITIVE |
| 2026-02-16 | FY25 Results Webinar |
Key Metrics
$690.0M
Market Cap
160K
Avg Volume
1.5x
Vol Ratio
$1.11 — $2.25
52-Week Range
0.0%
Short Interest
N/A
Cash Runway
-1221.3%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | pass | Near 52w High |
| S | Supply & Demand | neutral | Float: 86% |
| L | Leader vs Laggard | pass | RS: 11 |
| I | Institutional Sponsorship | pass | Inst: 18% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #24 of 119 · Sector avg: 51
View all Healthcare signals →